Iterum Therapeutics Statistics
Total Valuation
ITRM has a market cap or net worth of $21.12 million. The enterprise value is $31.02 million.
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ITRM has 22.71 million shares outstanding. The number of shares has increased by 16.06% in one year.
Shares Outstanding | 22.71M |
Shares Change (YoY) | +16.06% |
Shares Change (QoQ) | +7.25% |
Owned by Insiders (%) | 1.81% |
Owned by Institutions (%) | 3.05% |
Float | 21.96M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.82
Current Ratio | 0.82 |
Quick Ratio | 0.71 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -10.98 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -73.35% |
Return on Capital (ROIC) | -93.31% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.02M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ITRM has paid $382,000 in taxes.
Income Tax | 382,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.67% in the last 52 weeks. The beta is 2.25, so ITRM's price volatility has been higher than the market average.
Beta (5Y) | 2.25 |
52-Week Price Change | +28.67% |
50-Day Moving Average | 1.11 |
200-Day Moving Average | 1.41 |
Relative Strength Index (RSI) | 36.15 |
Average Volume (20 Days) | 174,381 |
Short Selling Information
The latest short interest is 215,246, so 0.95% of the outstanding shares have been sold short.
Short Interest | 215,246 |
Short Previous Month | 341,652 |
Short % of Shares Out | 0.95% |
Short % of Float | 0.98% |
Short Ratio (days to cover) | 0.63 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -38.26M |
Pretax Income | -35.05M |
Net Income | -28.34M |
EBITDA | -37.36M |
EBIT | -38.26M |
Earnings Per Share (EPS) | -$1.95 |
Full Income Statement Balance Sheet
The company has $11.72 million in cash and $21.62 million in debt, giving a net cash position of -$9.90 million or -$0.44 per share.
Cash & Cash Equivalents | 11.72M |
Total Debt | 21.62M |
Net Cash | -9.90M |
Net Cash Per Share | -$0.44 |
Equity (Book Value) | -10.91M |
Book Value Per Share | -0.66 |
Working Capital | -3.08M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$41.95 million and capital expenditures $1,000, giving a free cash flow of -$41.95 million.
Operating Cash Flow | -41.95M |
Capital Expenditures | 1,000 |
Free Cash Flow | -41.95M |
FCF Per Share | -$1.85 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ITRM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -16.06% |
Shareholder Yield | -16.06% |
Earnings Yield | -134.19% |
FCF Yield | -198.64% |
Analyst Forecast
The average price target for ITRM is $5.00, which is 437.63% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.00 |
Price Target Difference | 437.63% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on August 18, 2022. It was a reverse split with a ratio of 0.0666667:1.
Last Split Date | Aug 18, 2022 |
Split Type | Reverse |
Split Ratio | 0.0666667:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |